SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
January 30, 2024
 · 
4 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 04, 2023
December 4, 2023
 · 
1 min read
Genetown
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress
November 27, 2023
 · 
6 min read
Genetown
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
 · 
1 min read
Business
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
November 13, 2023
 · 
13 min read
Genetown
Astria Therapeutics Presents New Phase 1a Data Confirming Potential for STAR-0125 to Prevent Hereditary Angioedema Attacks with Dosing 2 or 4 Times Per Year
November 10, 2023
 · 
8 min read
Genetown
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference - November 9, 2023
November 9, 2023
 · 
1 min read
Genetown
Astria Therapeutics to Present New STAR-0215 Data at the 2023 American College of Allergy, Asthma, And Immunology Annual Scientific Meeting
November 3, 2023
 · 
5 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 02, 2023
November 2, 2023
 · 
1 min read
Business
Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th
October 30, 2023
 · 
1 min read
Load More